Amphastar P

Company Profile

Amphastar P had its IPO on 2014-06-25 under the ticker symbol AMPH.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Amphastar P has a staff strength of 1,615 employees.

Stock update

Shares of Amphastar P opened at $37.4 at the start of the last trading session i.e. 2023-03-19.

The stocks traded within a range of $36.03 - $37.4, and closed at $36.29.

This is a -3.48% slip from the previous day's closing price.

A total volume of 1,221,600 shares were traded at the close of the day’s session.

In the last one week, shares of Amphastar P have increased by +2.63%.

Amphastar P's Key Ratios

Amphastar P has a market cap of $1.68 billion, indicating a price to book ratio of 2.7899 and a price to sales ratio of 2.839.

In the last 12-months Amphastar P’s revenue was $498.99 million with a gross profit of $248.86 million and an EBITDA of $132.73 million. The EBITDA ratio measures Amphastar P's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Amphastar P’s operating margin was 21.54% while its return on assets stood at 9.51% with a return of equity of 18.76%.

In Q4, Amphastar P’s quarterly earnings growth was a positive 63.7% while revenue growth was a positive 11.7%.

Amphastar P’s PE and PEG Ratio

Forward PE

0

Trailing PE

20.982

PEG

2.77

Its diluted EPS in the last 12-months stands at $1.67 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 2.77. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Amphastar P’s profitability.

Amphastar P stock is trading at a EV to sales ratio of 2.74 and a EV to EBITDA ratio of 10.1191. Its price to sales ratio in the trailing 12-months stood at 2.839.

Amphastar P stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$741.99 million

Total Liabilities

$94.86 million

Operating Cash Flow

$-229000.00

Capital Expenditure

$22.98 million

Dividend Payout Ratio

0%

Amphastar P ended 2023 with $741.99 million in total assets and $0 in total liabilities. Its intangible assets were valued at $741.99 million while shareholder equity stood at $528.66 million.

Amphastar P ended 2023 with $0 in deferred long-term liabilities, $94.86 million in other current liabilities, 6000.00 in common stock, $271.72 million in retained earnings and $3.13 million in goodwill. Its cash balance stood at $156.10 million and cash and short-term investments were $175.76 million. The company’s total short-term debt was $6,049,000 while long-term debt stood at $72.84 million.

Amphastar P’s total current assets stands at $378.32 million while long-term investments were $2.41 million and short-term investments were $19.66 million. Its net receivables were $88.80 million compared to accounts payable of $84.24 million and inventory worth $103.58 million.

In 2023, Amphastar P's operating cash flow was $-229000.00 while its capital expenditure stood at $22.98 million.

Comparatively, Amphastar P paid $0 in dividends in 2023.

Other key metrics

Current Trading Price

$36.29

52-Week High

$44.46

52-Week Low

$26.76

Analyst Target Price

$41.25

Amphastar P stock is currently trading at $36.29 per share. It touched a 52-week high of $44.46 and a 52-week low of $44.46. Analysts tracking the stock have a 12-month average target price of $41.25.

Its 50-day moving average was $32.04 and 200-day moving average was $31.44 The short ratio stood at 8.95 indicating a short percent outstanding of 0%.

Around 2275.5% of the company’s stock are held by insiders while 6240.8% are held by institutions.